# Use of Zolpidem in Parkinson's Disease

> **NCT01351168** · PHASE2 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Levodopa
- **DRUG:** Zolpidem first dose
- **DRUG:** Zolpidem second dose
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT01351168
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study not funded
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351168, "Use of Zolpidem in Parkinson's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01351168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*